Testing Interruption of Hormonal Medications in Patients Responding Exceptionally to Therapy for Metastatic Prostate Cancer, (A-DREAM)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Atish D. Choudhury, MD, PhD
Dana-Farber Cancer Institute
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
326 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cancer Center at Saint Joseph'S
Phoenix, Arizona, United States
- Mercy Hospital Fort Smith
Fort Smith, Arkansas, United States
- Carti Cancer Center
Little Rock, Arkansas, United States
- Mission Hope Medical Oncology - Arroyo Grande
Arroyo Grande, California, United States
- Mercy Cancer Center �� Carmichael
Carmichael, California, United States
- Mercy San Juan Medical Center
Carmichael, California, United States
- Epic Care-Dublin
Dublin, California, United States
- Mercy Cancer Center - Elk Grove
Elk Grove, California, United States
- Bay Area Breast Surgeons Inc
Emeryville, California, United States
- Epic Care Partners in Cancer Care
Emeryville, California, United States
- Contra Costa Regional Medical Center
Martinez, California, United States
- Mercy Uc Davis Cancer Center
Merced, California, United States
- Bay Area Tumor Institute
Oakland, California, United States
- Uc Irvine Health/chao Family Comprehensive Cancer Center
Orange, California, United States
- Eisenhower Medical Center
Rancho Mirage, California, United States
- Mercy Cancer Center - Rocklin
Rocklin, California, United States
- Mercy Cancer Center - Sacramento
Sacramento, California, United States
- Pacific Central Coast Health Center-San Luis Obispo
San Luis Obispo, California, United States
- Mission Hope Medical Oncology - Santa Maria
Santa Maria, California, United States
- Epic Care Cyberknife Center
Walnut Creek, California, United States
- Woodland Memorial Hospital
Woodland, California, United States
- Rocky Mountain Regional Va Medical Center
Aurora, Colorado, United States
- Penrose-Saint Francis Healthcare
Colorado Springs, Colorado, United States
- Rocky Mountain Cancer Centers-Penrose
Colorado Springs, Colorado, United States
- Saint Francis Cancer Center
Colorado Springs, Colorado, United States
- Porter Adventist Hospital
Denver, Colorado, United States
- Mercy Medical Center
Durango, Colorado, United States
- Southwest Oncology Pc
Durango, Colorado, United States
- Saint Anthony Hospital
Lakewood, Colorado, United States
- Littleton Adventist Hospital
Littleton, Colorado, United States
- Longmont United Hospital
Longmont, Colorado, United States
- Parker Adventist Hospital
Parker, Colorado, United States
- Saint Mary Corwin Medical Center
Pueblo, Colorado, United States
- Um Sylvester Comprehensive Cancer Center at Aventura
Aventura, Florida, United States
- Um Sylvester Comprehensive Cancer Center at Coral Gables
Coral Gables, Florida, United States
- Um Sylvester Comprehensive Cancer Center at Deerfield Beach
Deerfield Beach, Florida, United States
- Um Sylvester Comprehensive Cancer Center at Kendall
Miami, Florida, United States
- University of Miami Miller School of Medicine-Sylvester Cancer Center
Miami, Florida, United States
- Um Sylvester Comprehensive Cancer Center at Plantation
Plantation, Florida, United States
- Saint Alphonsus Cancer Care Center-Boise
Boise, Idaho, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Nov 2022
- Primary completion
- 29 Sept 2025
- Completion
- 1 Sept 2033
- Last update posted
- 22 Dec 2025
- Registered enrollment
- 79
- Registry id
- NCT05241860
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.